| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |